Dr. Mark Y. Lee, MD

Dr. Lee practices at Memorial Cardiology Medical Group, Inc in Long Beach, California.

Dr. Lee's NPI, 1487943510, was assigned on March 29, 2011. Dr. Lee graduated from The Robert Larner, M.D. College of Medicine in 2009. Dr. Lee holds California license 116281.

Dr. Lee's primary practice is Memorial Cardiology Medical Group, Inc, at 2898 Linden Ave, Long Beach, CA 90806 in Los Angeles County. The practice phone is (562) 595-8671.

Dr. Lee's primary practice is Memorial Cardiology Medical Group, Inc in Long Beach, California. Dr. Lee is also affiliated with Long Beach Medical Center. The medical group on file is Memorial Cardiology Medical Group. Dmand AI also links Dr. Lee to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 3 sites in all. Vendor and product names are available with a free account.

Clinical cardiac electrophysiology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RC0001X. Dr. Lee is board certified in cardiac electrophysiology by the American Board of Internal Medicine. Dmand AI has Dr. Lee's licenses on file in 2 states: California and Vermont.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, heart blockage and heart failure among the conditions Dr. Lee treats.

CMS data shows 4,527 Medicare services from Dr. Lee across 38 procedure codes in 2024, for 650 Medicare patients. Medicare paid $456,963 for them.

CMS counts 650 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 266 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 69, with 46% women.

In 2024, Dr. Lee wrote 1,500 Medicare Part D claims for 300 patients. 72% of them were for generic drugs. CMS names the drug for 1,323 of them, across 26 drugs with 11 or more claims each, at $488,524 in total drug cost. In 2023, CMS named 1,369 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Lee for performance year 2024, reported as part of a group. Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth. CMS counts 33 procedures of pacemaker insertion or repair by Dr. Lee, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Lee, published from 2011 to 2024. 2021 was the busiest year, with 2. The most frequent topics are Atrial Fibrillation and Catheter Ablation. Dr. Lee's most frequent co-authors are Andrea Natale, MD, Adrian Harry Shandling, MD and Rajesh S. Banker, MD.

Dmand AI links Dr. Lee to 5 clinical trials, 3 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Atrial Fibrillation, Arrhythmias, Cardiac and Atherosclerosis. InCarda Therapeutics, Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Lee that name 1 trial.

CMS Open Payments shows 1,233 general payments to Dr. Lee from 65 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. Biosense Webster, Inc. paid the most, $74,296. It also lists 2 research payments totaling $26,233 in 2024, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Lee, most recently Attending of the Year in 2018.

Dr. Lee graduated from The Robert Larner, M.D. College of Medicine in 2009. Dr. Lee is a member of ACC and AHA.

Dr. Lee is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.